From: Can exhaled NO fraction predict radiotherapy-induced lung toxicity in lung cancer patients?
Lung cancer patients (n = 65) | |
---|---|
Males/Females | 48/17 |
Age (years, mean (SD)) | 61 (11) |
Smoking history | Current smoker 13 |
Ex smoker 49 | |
Never smoker 3 | |
Histology and stage | NSCLC |
squamous : 32 | |
adenocarcinoma : 12 | |
large cell : 4 | |
unspecified : 4 | |
Stage : I : 1 | |
II : 4 | |
III : 47 | |
SCLC : 13 | |
Stage : limited: | |
Treatment | sequential chemo-RT : 21 |
concurrent chemo-RT : 40 | |
no chemotherapy : 4 | |
lung resection before RT : 14 | |
DVH (mean (SD)) | V5: 45% (15%) |
V13: 31% (12%) | |
V20: 24% (10%) | |
V30: 17% (8%) | |
MLD: 12.9 Gy (4.6 Gy) | |
Baseline PFT | Normal values : 15 Restrictive ventilatory defect : 13 |
Obstructive ventilatory defect : 37 |